{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T06:59:15Z","timestamp":1787900355930,"version":"build-2784847793"},"reference-count":181,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2014,8,27]],"date-time":"2014-08-27T00:00:00Z","timestamp":1409097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Movement Disorders"],"published-print":{"date-parts":[[2014,9,15]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Therapeutic decision\u2010making in Huntington's disease (HD) is often guided by clinical experience, because of the limited empirical evidence available. The only medication for HD that has met the regulatory hurdle for approval is tetrabenazine, indicated for the treatment of chorea. However, its use has limitations, and in the setting of specific contraindications or comorbidities the treatment of choice for chorea is still the multipurpose antipsychotics. For the management of psychiatric disturbances, selective serotonin reuptake inhibitors (SSRIs) and mood stabilizers are often used, although empirical evidence is lacking. Finally, no known effective treatment is available for cognitive dysfunction in HD. We discuss the limited evidence available and current expert opinion on medical treatment of the dominant motor, psychiatric, and cognitive features of HD. This follows a brief introduction on the general principles of HD management and on evidence\u2010based medicine in relation to clinical practice. \u00a9 2014 International Parkinson and Movement Disorder Society<\/jats:p>","DOI":"10.1002\/mds.26014","type":"journal-article","created":{"date-parts":[[2014,8,27]],"date-time":"2014-08-27T12:11:16Z","timestamp":1409141476000},"page":"1404-1413","source":"Crossref","is-referenced-by-count":59,"title":["Current therapeutic options for Huntington's disease: Good clinical practice versus evidence\u2010based approaches?"],"prefix":"10.1002","volume":"29","author":[{"given":"Annie","family":"Killoran","sequence":"first","affiliation":[{"name":"West Virginia University Morgantown West Virginia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Biglan","sequence":"additional","affiliation":[{"name":"University of Rochester Rochester New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,8,27]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1371\/currents.RRN1260"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nurt.2008.01.008"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-013-0244-z"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.312.7023.71"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318263c443"},{"key":"e_1_2_9_7_1","volume-title":"Effectiveness and Efficiency: Random Reflections on Health Services","author":"Cochrane AL","year":"1972"},{"key":"e_1_2_9_8_1","first-page":"1162","article-title":"Is evidence\u2010based medicine overrated in family medicine? No","volume":"59","author":"Labrecque M","year":"2013","journal-title":"Can Fam Physician"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2753.2008.01009.x"},{"key":"e_1_2_9_10_1","first-page":"1435","article-title":"The limits of evidence\u2010based medicine","volume":"46","author":"Tonelli MR","year":"2001","journal-title":"Respir Care"},{"key":"e_1_2_9_11_1","unstructured":"QaseemA. A perspective on the guidelines international network and the institute of medicine's proposed standards for guideline development. [Internet] Maryland: Agency for Healthcare Research and Quality;2013 Apr 8. [cited 2014 Month 04]. Available from:http:\/\/www.guideline.gov\/expert\/expert\u2010commentary.aspx?id=43913."},{"key":"e_1_2_9_12_1","article-title":"Evidence\u2010based medicine: do clinical practice guidelines contribute to better patient care?","author":"Jacobson JO","year":"2014","journal-title":"Medscape."},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(97)00244-1"},{"key":"e_1_2_9_14_1","first-page":"CD006456","article-title":"Therapeutic interventions for symptomatic treatment in Huntington's disease","volume":"3","author":"Mestre T","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2011.10.021"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-012-0165-x"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-013-0219-8"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23953"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-381328-2.00013-4"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.2165\/11534430-000000000-00000"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21971"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1371\/currents.RRN1259"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1371\/currents.RRN1261"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/lary.24175"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11017-007-9029-x"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2011.02681.x"},{"key":"e_1_2_9_27_1","volume-title":"Evidence\u2010Based Medicine: How to Practice and Teach EBM","author":"Straus S","year":"2005"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-009-0048-7"},{"key":"e_1_2_9_29_1","article-title":"Clinical guidelines strengthened by evidence\u2010based practice","author":"Watters WC","year":"2014","journal-title":"American Academy of Orthopedic Surgeons"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2012.09.023"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.2012.01105.x"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/15563650701665142"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/631803"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2013.773310"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/det457"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2012-3496"},{"issue":"5","key":"e_1_2_9_37_1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1017\/S0317167100118943","article-title":"Canadian Headache Society Acute Migraine Treatment Guideline Development Group. Canadian Headache Society Guideline: acute drug therapy for migraine headache","volume":"40","author":"Worthington I","year":"2013","journal-title":"Can J Neurol Sci"},{"key":"e_1_2_9_38_1","first-page":"6","article-title":"The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary","author":"Alexopoulos GS","year":"2005","journal-title":"Postgrad Med"},{"key":"e_1_2_9_39_1","first-page":"13:340","article-title":"Guidelines for the use and management of long\u2010acting injectable antipsychotics in serious mental illness","volume":"20","author":"Llorca PM","year":"2013","journal-title":"BMC Psychiatry"},{"key":"e_1_2_9_40_1","unstructured":"American Psychiatric Association. [cited February 2014]. Available from:.http:\/\/www.psych.org\/practice\/clinical\u2010practice\u2010guidelines\/Expert\u2010Opinion\u2010Panels"},{"key":"e_1_2_9_41_1","unstructured":"American Medical Association. [cited February 2014]. Available from:http:\/\/www.ama\u2010.assn.org\/resources\/doc\/PolicyFinder\/policyfiles\/HnE\/H\u2010410.953.HTM"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-11-65"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.324.7350.1350"},{"key":"e_1_2_9_44_1","doi-asserted-by":"crossref","first-page":"A8","DOI":"10.7326\/ACPJC-2007-146-1-A08","article-title":"Misunderstandings, misperceptions, and mistakes","volume":"146","author":"Straus S","year":"2007","journal-title":"ACP J Club"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25500"},{"key":"e_1_2_9_46_1","unstructured":"GoodmanL. The flaw in the AAN Chorea Guidelines. Huntington's Disease Drug Works. [cited 2012 July 23]. Available from:http:\/\/hddrugworks.org\/index.php?option=com_content&task=view&id=312."},{"key":"e_1_2_9_47_1","unstructured":"VetterL. American Academy of Neurology [letter]. [cited 2012 July 9]. Available from:http:\/\/www.hdsa.org\/images\/content\/1\/7\/17235\/2012\u201007\u201006%20AAN%20letter%20to%20HDSA.PDF"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2003.017822"},{"key":"e_1_2_9_49_1","first-page":"PMC3822048","article-title":"Safety and efficacy of tetrabenazine and use of concomitant medications during long\u2010term, open\u2010label treatment of chorea associated with Huntington's and other diseases","volume":"3","author":"Shen V","year":"2013","journal-title":"Tremor Other Hyperkinet Mov"},{"key":"e_1_2_9_50_1","unstructured":"Briefing Memo Food and Drug Aministration. [cited 2007 December 6]. Available from:http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/07\/briefing\/2007\u20104328b1\u201001\u2010FDA.pdf"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000198586.85250.13"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.74.1.120"},{"key":"e_1_2_9_53_1","first-page":"3539","article-title":"Clozapine versus placebo in Huntington's disease: a double blind randomised comparative study","volume":"63","author":"Vugt JPP","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-9-62"},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000086373.32347.16"},{"key":"e_1_2_9_56_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.36.2.244"},{"key":"e_1_2_9_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870050202"},{"key":"e_1_2_9_58_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182a55f05"},{"key":"e_1_2_9_59_1","doi-asserted-by":"publisher","DOI":"10.1007\/s100720170066"},{"key":"e_1_2_9_60_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1355617711000725"},{"key":"e_1_2_9_61_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.55.6.801"},{"key":"e_1_2_9_62_1","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0b013e318166da60"},{"key":"e_1_2_9_63_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085430"},{"key":"e_1_2_9_64_1","doi-asserted-by":"publisher","DOI":"10.2165\/11208330-000000000-00000"},{"key":"e_1_2_9_65_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2013.00081"},{"key":"e_1_2_9_66_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.54.2.452"},{"key":"e_1_2_9_67_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22412"},{"key":"e_1_2_9_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2011.10.031"},{"key":"e_1_2_9_69_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1320240211"},{"key":"e_1_2_9_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2010.04.030"},{"key":"e_1_2_9_71_1","volume-title":"Xenazine [package insert]"},{"key":"e_1_2_9_72_1","doi-asserted-by":"publisher","DOI":"10.1371\/currents.RRN1293"},{"key":"e_1_2_9_73_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.60.7.996"},{"key":"e_1_2_9_74_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000050"},{"key":"e_1_2_9_75_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31824e8f0d"},{"key":"e_1_2_9_76_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.59.5.694"},{"key":"e_1_2_9_77_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21181"},{"key":"e_1_2_9_78_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000096019.71649.2B"},{"key":"e_1_2_9_79_1","unstructured":"Tetrabenazine drug monograph. Food and Drug Administration. [cited 2014 February]. Available from:http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/cfrsearch.cfm?fr=1308.12."},{"key":"e_1_2_9_80_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22809"},{"key":"e_1_2_9_81_1","unstructured":"GassullMA. Relevant end\u2010points and outcome variables. What can we learn from the Editor? Evidence\u2010based medicine in clinical nutrition. Symposium. 23rd Congress of the European Society for Parenteral and Enteral Nutrition Munich. 9\u201012 September2001."},{"key":"e_1_2_9_82_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-282X2004000600030"},{"key":"e_1_2_9_83_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e3283407775"},{"key":"e_1_2_9_84_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199902000-00020"},{"key":"e_1_2_9_85_1","doi-asserted-by":"publisher","DOI":"10.1080\/10401230701844802"},{"key":"e_1_2_9_86_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e3283407775"},{"key":"e_1_2_9_87_1","first-page":"1353","article-title":"Clinical experience with risperidone and memantadine in the treatment of Huntington's disease","volume":"98","author":"Cankurtaran ES","year":"2006","journal-title":"J Natl Med Assoc"},{"key":"e_1_2_9_88_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1331.2002.0354e.x"},{"key":"e_1_2_9_89_1","doi-asserted-by":"publisher","DOI":"10.3109\/10401239809148945"},{"key":"e_1_2_9_90_1","first-page":"347","article-title":"Use of risperidone in psychosis associated with Huntington's disease","volume":"6","author":"Madhusoodanan S","year":"1998","journal-title":"Am J Geriatr Psychiatry"},{"key":"e_1_2_9_91_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199704000-00023"},{"key":"e_1_2_9_92_1","doi-asserted-by":"publisher","DOI":"10.1177\/026988119601000213"},{"key":"e_1_2_9_93_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1331.2002.0354f.x"},{"key":"e_1_2_9_94_1","first-page":"524","article-title":"Olanzapine improves chorea in patients with Huntington's disease [In Spanish]","volume":"35","author":"Jim\u00e9nez\u2010Jim\u00e9nez FJ","year":"2002","journal-title":"Rev Neurol"},{"key":"e_1_2_9_95_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200203000-00009"},{"key":"e_1_2_9_96_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.67.1.123"},{"key":"e_1_2_9_97_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-200209000-00007"},{"key":"e_1_2_9_98_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0404.2002.01197.x"},{"key":"e_1_2_9_99_1","first-page":"69","article-title":"Shortterm effects of olanzapine in Huntington's disease","volume":"14","author":"Squitieri F","year":"2001","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"key":"e_1_2_9_100_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-282X1999000500021"},{"key":"e_1_2_9_101_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.47.8.844"},{"key":"e_1_2_9_102_1","doi-asserted-by":"publisher","DOI":"10.1177\/026988119601000213"},{"key":"e_1_2_9_103_1","doi-asserted-by":"publisher","DOI":"10.1177\/026988119400800411"},{"key":"e_1_2_9_104_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-002-0741-1"},{"key":"e_1_2_9_105_1","doi-asserted-by":"publisher","DOI":"10.1177\/070674370404900617"},{"key":"e_1_2_9_106_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881103174009"},{"key":"e_1_2_9_107_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.474"},{"key":"e_1_2_9_108_1","first-page":"1","article-title":"Aripiprazole in the treatment of Huntington's disease: a case series","volume":"5","author":"Ciammola A","year":"2009","journal-title":"Neuropsychiatr Dis Treat"},{"key":"e_1_2_9_109_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.neuropsych.22.3.352-c.e4"},{"key":"e_1_2_9_110_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.neuropsych.12040097"},{"key":"e_1_2_9_111_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2008.08040503"},{"key":"e_1_2_9_112_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.38.1.84"},{"key":"e_1_2_9_113_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.35.10.1450"},{"key":"e_1_2_9_114_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.47.8.848"},{"key":"e_1_2_9_115_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.47.8.848"},{"key":"e_1_2_9_116_1","first-page":"177","article-title":"Fluphenazine decanoate in the treatment of chorea:a double\u2010blind study","volume":"20","author":"Terrence CF","year":"1976","journal-title":"Curr Ther Res Clin Exp"},{"key":"e_1_2_9_117_1","first-page":"1","article-title":"Effect of oral fluphenazine on Huntington's chorea","volume":"4","author":"Whittier JR","year":"1968","journal-title":"Int J Neuropsychiatry"},{"key":"e_1_2_9_118_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01573339"},{"key":"e_1_2_9_119_1","first-page":"573","article-title":"Huntington's disease: clinical effects of a short\u2010term treatment with pimozide","volume":"24","author":"Arena R","year":"1980","journal-title":"Adv Biochem Psychopharmacol"},{"key":"e_1_2_9_120_1","first-page":"307","article-title":"Therapeutic experiences in the treatment of hyperkineses with the neuroleptic pimozide (Antalon, Orap) in the frame of Huntington chorea","volume":"34","author":"Siegmund R","year":"1982","journal-title":"Psychiatr Neurol Med Psychol (Leipz)"},{"key":"e_1_2_9_121_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007998409109601"},{"key":"e_1_2_9_122_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.47.8.848"},{"key":"e_1_2_9_123_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.48.3.292"},{"key":"e_1_2_9_124_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22376"},{"key":"e_1_2_9_125_1","first-page":"282","article-title":"Huntington disease: tetrabenazine compared to haloperidol in the reduction of involuntary movements [in Spanish]","volume":"4","author":"Gim\u00e9nez\u2010Rold\u00e1n S","year":"1989","journal-title":"Neurologia"},{"key":"e_1_2_9_126_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v62n0906"},{"key":"e_1_2_9_127_1","article-title":"Off\u2010label use of atypical antipsychotics: lack of evidence for their use in primary insomnia","author":"Park SH","year":"2013","journal-title":"Formulary Watch"},{"key":"e_1_2_9_128_1","unstructured":"MaglioneM Ruelaz MaherA HuJ et al. Off\u2010label use of atypical antipsychotics: an update. Comparative Effectiveness Review No. 43. (Prepared by the Southern California Evidence\u2010based Practice Center under Contract No. HHSA290\u20102007\u201010062\u20101.) Rockville MD: Agency for Healthcare Research and Quality. [cited 2011 September]. Available from:www.effectivehealthcare.ahrq.gov\/reports\/final.cfm."},{"key":"e_1_2_9_129_1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.5694\/j.1326-5377.1976.tb140550.x","article-title":"Clonazepam in the treatment of choreiform activity","volume":"1","author":"Peiris JB","year":"1976","journal-title":"Med J Aust"},{"key":"e_1_2_9_130_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.wnf.0000186648.93612.a5"},{"key":"e_1_2_9_131_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21061"},{"key":"e_1_2_9_132_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.wnf.0000169732.00690.32"},{"key":"e_1_2_9_133_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.WNF.0000240946.51994.DF"},{"key":"e_1_2_9_134_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25237"},{"key":"e_1_2_9_135_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-013-0216-3"},{"key":"e_1_2_9_136_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2012-303688"},{"key":"e_1_2_9_137_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-6-11"},{"key":"e_1_2_9_138_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(98)00025-6"},{"key":"e_1_2_9_139_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-012-6510-x"},{"key":"e_1_2_9_140_1","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8257(200001)15:1<171::AID-MDS1031>3.0.CO;2-Y"},{"key":"e_1_2_9_141_1","doi-asserted-by":"publisher","DOI":"10.1016\/0303-8467(80)90017-7"},{"key":"e_1_2_9_142_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.68.2.238"},{"key":"e_1_2_9_143_1","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1974.tb47770.x"},{"key":"e_1_2_9_144_1","first-page":"45","article-title":"Huntington's chorea: the rigid form (Westphal variant) treated with l\u2010DOPA: a case report","volume":"10","author":"Low PA","year":"1973","journal-title":"Proc Aust Assoc Neurol"},{"key":"e_1_2_9_145_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.65.4.577"},{"key":"e_1_2_9_146_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-200201000-00011"},{"key":"e_1_2_9_147_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1E004"},{"key":"e_1_2_9_148_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e3283348018"},{"key":"e_1_2_9_149_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25750"},{"key":"e_1_2_9_150_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130000575"},{"key":"e_1_2_9_151_1","first-page":"367","article-title":"A case of obsessive symptoms in Huntington's disease","volume":"31","author":"Royuela Rico A","year":"2003","journal-title":"Actas Esp Psiquiatr"},{"key":"e_1_2_9_152_1","first-page":"216","article-title":"Obsessive compulsive disorder in Huntington disease: a case of isolated obsessions successfully treated with sertraline","volume":"15","author":"Patzold T","year":"2002","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"key":"e_1_2_9_153_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870120319"},{"key":"e_1_2_9_154_1","doi-asserted-by":"publisher","DOI":"10.1176\/jnp.8.3.338"},{"key":"e_1_2_9_155_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3182(97)71447-6"},{"key":"e_1_2_9_156_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.151.7.1097a"},{"key":"e_1_2_9_157_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3182(93)71857-5"},{"key":"e_1_2_9_158_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1C352"},{"key":"e_1_2_9_159_1","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2007.9.2\/arosenblatt"},{"key":"e_1_2_9_160_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200009283431316"},{"key":"e_1_2_9_161_1","doi-asserted-by":"publisher","DOI":"10.1080\/15622970701332520"},{"key":"e_1_2_9_162_1","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5545.105522"},{"key":"e_1_2_9_163_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(74)90847-2"},{"key":"e_1_2_9_164_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31829c9748"},{"key":"e_1_2_9_165_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.47.1.70"},{"key":"e_1_2_9_166_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.12.1966"},{"key":"e_1_2_9_167_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1331.2002.0354e.x"},{"key":"e_1_2_9_168_1","first-page":"347","article-title":"Use of risperidone in psychosis associated with Huntington's disease","volume":"6","author":"Madhusoodanan S","year":"1998","journal-title":"Am J Geriatr Psychiatry"},{"key":"e_1_2_9_169_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.neuropsych.21.1.97"},{"key":"e_1_2_9_170_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2008.08040503"},{"key":"e_1_2_9_171_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.45.3.247"},{"key":"e_1_2_9_172_1","first-page":"106","article-title":"Aggressive behavior in Huntington's disease: treatment with propranolol","volume":"48","author":"Stewart JT","year":"1987","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_9_173_1","doi-asserted-by":"publisher","DOI":"10.1176\/jnp.6.2.154"},{"key":"e_1_2_9_174_1","doi-asserted-by":"publisher","DOI":"10.1176\/jnp.8.2.209"},{"key":"e_1_2_9_175_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3181b2ac0a"},{"key":"e_1_2_9_176_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000238106.10423.00"},{"key":"e_1_2_9_177_1","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8257(200001)15:1<173::AID-MDS1032>3.0.CO;2-T"},{"key":"e_1_2_9_178_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2006.08.005"},{"key":"e_1_2_9_179_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-008-1068-0"},{"key":"e_1_2_9_180_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1331.2002.00447_4.x"},{"key":"e_1_2_9_181_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.wnf.0000240945.44370.f0"},{"key":"e_1_2_9_182_1","doi-asserted-by":"publisher","DOI":"10.1176\/jnp.6.1.62"}],"container-title":["Movement Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmds.26014","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mds.26014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T11:05:55Z","timestamp":1760958355000},"score":1,"resource":{"primary":{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/10.1002\/mds.26014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,27]]},"references-count":181,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,9,15]]}},"alternative-id":["10.1002\/mds.26014"],"URL":"https:\/\/doi.org\/10.1002\/mds.26014","archive":["Portico"],"relation":{},"ISSN":["0885-3185","1531-8257"],"issn-type":[{"value":"0885-3185","type":"print"},{"value":"1531-8257","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,27]]}}}